Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease

Fig. 3

Mean (a) Gastrointestinal Symptom Rating Scale and (b) Quality of Life in Reflux and Dyspepsia questionnaire scores at baselinea, following 4 weeks’ initial (short-term) treatment with esomeprazole 20 mg once daily, and after maintenance treatment with either on-demand or continuous esomeprazole for 6 months (intention-to-treat population). aBaseline corresponds to visit 1 (week −4). *P < 0.01 and **P ≤ 0.001 for the difference in the change in scores from baseline to the end of maintenance treatment for continuous versus on-demand treatment groups

Back to article page